Before taking TAZVERIK(Tazemetostat)

Tazemetostat may increase the risk of secondary malignancies and fetal harm, requiring specific precautions.

Warnings and Precautions for Tazemetostat

Tazemetostat carries a risk of developing secondary malignancies, including myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and other hematologic cancers. It should not be used during pregnancy as it may cause fetal harm, and patients should use effective non-hormonal contraception during treatment and for six months after the last dose. The drug also poses risks of hematologic issues, and long-term monitoring is required for secondary malignancies.

Related Columns

Tazemetostat(TAZVERIK)

Adults and children with unresectable metastatic or locally advanced...

WeChat Scan
Free Inquiry

Things to note when using tazemetostat

Tazemetostat is a new generation of oral tyrosine kinase inhibitors, designed specifically for a variety of hematologic and solid-related diseases. By accurately blocking abnormal cell signaling ...

How to use Tazemetostat and its precautions

Tazemetostat is an innovative targeted therapeutic drug, mainly used to treat specific types of related diseases. By accurately inhibiting the key signaling pathways in the growth of cells in rel...

Things to note when using Tazemetostat

Tazemetostat is an innovative targeted therapeutic drug, mainly used to treat certain specific types of hemologic diseases, such as multiple bone marrow-related diseases. By accurately inhibiting...